A detailed history of Envestnet Asset Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 425,419 shares of FOLD stock, worth $3.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
425,419
Previous 418,215 1.72%
Holding current value
$3.91 Million
Previous $4.47 Million 10.28%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$9.36 - $12.01 $67,429 - $86,520
7,204 Added 1.72%
425,419 $4.01 Million
Q3 2024

Nov 06, 2024

SELL
$9.55 - $12.09 $311,406 - $394,230
-32,608 Reduced 7.23%
418,215 $4.47 Million
Q2 2024

Aug 08, 2024

BUY
$9.04 - $11.75 $147,017 - $191,090
16,263 Added 3.74%
450,823 $4.47 Million
Q1 2024

May 13, 2024

BUY
$11.43 - $14.24 $219,204 - $273,094
19,178 Added 4.62%
434,560 $5.12 Million
Q4 2023

Feb 13, 2024

BUY
$9.97 - $14.52 $215,890 - $314,416
21,654 Added 5.5%
415,382 $5.89 Million
Q3 2023

Nov 13, 2023

BUY
$11.78 - $13.86 $2.92 Million - $3.44 Million
248,220 Added 170.59%
393,728 $4.79 Million
Q2 2023

Aug 04, 2023

BUY
$10.72 - $13.3 $2,669 - $3,311
249 Added 0.17%
145,508 $1.83 Million
Q1 2023

May 11, 2023

BUY
$10.91 - $13.54 $12,895 - $16,004
1,182 Added 0.82%
145,259 $1.61 Million
Q4 2022

Feb 07, 2023

BUY
$9.89 - $12.7 $319,011 - $409,651
32,256 Added 28.85%
144,077 $1.76 Million
Q3 2022

Nov 10, 2022

SELL
$9.82 - $12.75 $73,483 - $95,408
-7,483 Reduced 6.27%
111,821 $1.17 Million
Q2 2022

Aug 03, 2022

BUY
$6.23 - $11.12 $96,602 - $172,426
15,506 Added 14.94%
119,304 $1.28 Million
Q1 2022

May 04, 2022

SELL
$7.89 - $12.48 $86,482 - $136,793
-10,961 Reduced 9.55%
103,798 $983,000
Q4 2021

Feb 04, 2022

BUY
$9.82 - $12.44 $298,341 - $377,939
30,381 Added 36.01%
114,759 $1.33 Million
Q3 2021

Oct 07, 2021

BUY
$8.74 - $11.84 $107,432 - $145,537
12,292 Added 17.05%
84,378 $806,000
Q2 2021

Aug 04, 2021

SELL
$8.71 - $10.72 $180,140 - $221,711
-20,682 Reduced 22.29%
72,086 $695,000
Q1 2021

May 04, 2021

BUY
$9.2 - $23.86 $540,739 - $1.4 Million
58,776 Added 172.91%
92,768 $917,000
Q4 2020

Feb 02, 2021

BUY
$13.47 - $24.89 $28,542 - $52,741
2,119 Added 6.65%
33,992 $785,000
Q3 2020

Oct 09, 2020

BUY
$12.89 - $15.89 $410,842 - $506,461
31,873 New
31,873 $450,000
Q3 2018

Nov 14, 2018

SELL
$11.6 - $16.54 $24,708 - $35,230
-2,130 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$13.13 - $17.09 $748 - $974
57 Added 2.75%
2,130 $33,000
Q1 2018

May 09, 2018

SELL
$13.76 - $17.12 $1,417 - $1,763
-103 Reduced 4.73%
2,073 $31,000
Q4 2017

Feb 20, 2018

BUY
$12.51 - $16.24 $2,964 - $3,848
237 Added 12.22%
2,176 $31,000
Q3 2017

Nov 13, 2017

BUY
$11.74 - $15.78 $22,763 - $30,597
1,939
1,939 $29,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.58B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.